LG Life Sciences Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares LG Life Sciences Ltd with three other
pharmaceutical manufacturers in Asia:
Yifan Pharmaceutical Co Ltd
sales of 2.43 billion Chinese Renmimbi [US$361.21 million]
of which 68%
was Health Products - Medicine),
(30.90 billion Indian Rupees [US$463.16 million]
of which 73%
was Pharma), and
Shanghai Raas Blood Products Company Limited
based in China
(2.01 billion Chinese Renmimbi [US$298.68 million]
of which 97%
was Blood products production and sales).
LG Life Sciences Ltd reported sales of 450.53 billion Korean Won (US$400.52 million)
December of 2015.
increase of 5.9%
versus 2014, when the company's sales were 425.60 billion Korean Won.
Sales at LG Life Sciences Ltd have increased during each of the previous five years
(and since 2010, sales have increased a total of 35%).
Sales of Veterinary Pharmaceutical Products saw an increase
9.0% in 2015, from
356.47 billion Korean Won to 388.43 billion Korean Won.
Not all segments of LG Life Sciences Ltd experienced an increase in sales in 2015:
sales of Precision Chemical Segment fell 10.2% to 62.10 billion Korean Won.